Plate Nº 71 · recorded November 16, 2026
Health & Medicine ResearchReported finding
Experimental urine test spots UTI bacteria in about five hours
An engineered-virus test helped identify major UTI bacteria in about five hours across 206 urine samples, but group-level performance varied and clinical use remains unproven.
By Elena Vasquez4 min read756 words
In brief
- The diagnostic experiment tested 206 patient urine samples.
- The glow could help identify E. coli, Klebsiella and Enterococcus in about five hours.
- Test performance differed among the three bacterial groups.
- Standard laboratory identification may take days, delaying targeted antibiotic selection.
- A separate study tested engineered phages that release bacteria-killing proteins, but use in people remains unproven.

By Elena Vasquez
In a study of 206 patient urine samples, an experimental test helped identify major UTI-causing bacteria in about five hours, though performance varied by bacterial group. The approach could eventually give doctors faster information for choosing a more suitable treatment.
The work, published in Nature Communications, came from scientists at ETH Zurich and Balgrist University Hospital in Switzerland. The team focused on three important groups of bacteria that cause urinary tract infections:
- E. coli
- Klebsiella
- Enterococcus
What could the faster test change?
Standard laboratory tests may take days to identify the bacteria involved in a urinary tract infection. During that wait, doctors sometimes start treatment before knowing which antibiotic is most suitable.
A urinary tract infection, commonly called a UTI, happens when bacteria enter the urinary system, usually affecting the bladder. Symptoms can include burning during urination, frequent trips to the toilet and lower belly pain. In some cases, infection spreads to the kidneys and becomes more serious.
Women are particularly likely to develop UTIs, and some people have repeated infections. Antibiotics usually help, but bacteria are increasingly developing resistance to these medicines. Resistance means that a drug may no longer kill the bacteria or stop their growth, which can make treatment selection harder.
The new method did not remove that uncertainty. Its five-hour result came from the three targeted groups, and the test's performance differed among them. The findings therefore point toward a possible diagnostic tool rather than a universal answer for every UTI.
For patients, a much shorter wait looks possible, but routine clinical use has not been established.
How do phages make bacteria glow?
Scientists used bacteriophages, also called phages. These are viruses that infect particular bacteria rather than human cells. Their narrow range of bacterial targets gave the team a way to detect selected bacteria through a visible signal.
The researchers engineered the phages to produce light when they infected their bacterial targets. Infection of a matching bacterium activated the light-producing system, allowing the team to use the glow to detect that target in a urine sample.
Across 206 patient samples, this glowing signal could help identify E. coli, Klebsiella and Enterococcus within about five hours. The researchers reported different performance between the bacterial groups, so the glow was not equally informative for every target.
The test's basic logic is simple: a phage infects only certain bacteria, and the engineered virus lights up after that infection. It converts a biological event into a signal researchers can measure without waiting for the days-long identification process used in standard testing.
The test uses infection itself as the signal, reducing the reported identification time to about five hours.
Could engineered phages treat UTIs more precisely?
In a separate study in the same journal, researchers modified phages to release bacteria-killing proteins. They aimed to make the viruses more effective at eliminating bacteria and reduce bacterial resistance.
That approach differs from conventional antibiotics. Antibiotics may affect many kinds of bacteria, including helpful ones, whereas a phage-based treatment could potentially target more precisely the bacteria responsible for an infection. The added proteins were intended to improve the treatment's bacteria-killing action.
The diagnostic and treatment studies addressed related but separate problems. One sought faster identification of the cause of an infection. The other asked whether phages could be made to treat the infection more precisely. Sharing the same type of virus did not make them equivalent stages of development.
Phages may offer a narrower treatment route, but the study has not shown that they can safely or effectively replace antibiotics in people.
What must happen before clinics can use this?
The findings do not mean phage treatment is ready for routine use. The rapid diagnostic test needs further assessment in everyday healthcare. Researchers must learn whether its roughly five-hour performance carries over to routine care, given that results differed among bacterial groups.
Researchers must test the modified treatment for safety and effectiveness in people. They also need to determine whether a phage that kills a target bacterium can provide a useful, precise treatment without the broader effects associated with antibiotics.
For now, people with UTI symptoms should seek appropriate medical advice, especially if they develop fever, back pain or feel seriously unwell. The work offers a promising route toward faster diagnosis and more targeted care, rather than a proven replacement for antibiotics.
The research has produced a credible five-hour diagnostic signal, but patients should not yet expect it to guide routine phage-based care.
via knowridge.com (Source)
More from Elena Vasquez
Show full bio
Correspondent covering money, funding and market shifts around general science news at SciBeat.
451 articles
Nearby plates
- Lab-Grown 'Mini-Bladder' May Explain Why UTIs Keep Coming Back
- FDA-Cleared Urine Test Detects Deadly Mold Infection Within Hours
- Researchers track two pathways behind recurrent bacterial vaginosis
- Urine RNA test detects bladder cancer with 95% accuracy in 683-sample study
- Stable Genes, Not Shuffling, Made a Superbug Dominant — Then It Fell